Changes in Testing and Treatment Methods in Osteoporosis Care
Osteoporosis treatment plays a crucial role in preventing fractures, particularly in bedridden patients. We conducted a questionnaire survey presenting hypothetical clinical cases in 2015 and 2020 to investigate trends over a 5-year period. The target population included physicians working in clinic...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Osteoporosis |
| Online Access: | http://dx.doi.org/10.1155/2024/9629891 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553208056119296 |
|---|---|
| author | Takashi Nagai Koji Ishikawa Koki Tsuchiya Soji Tani Yusuke Dodo Yusuke Oshita Keizo Sakamoto Nobuyuki Kawate Yoshifumi Kudo |
| author_facet | Takashi Nagai Koji Ishikawa Koki Tsuchiya Soji Tani Yusuke Dodo Yusuke Oshita Keizo Sakamoto Nobuyuki Kawate Yoshifumi Kudo |
| author_sort | Takashi Nagai |
| collection | DOAJ |
| description | Osteoporosis treatment plays a crucial role in preventing fractures, particularly in bedridden patients. We conducted a questionnaire survey presenting hypothetical clinical cases in 2015 and 2020 to investigate trends over a 5-year period. The target population included physicians working in clinics and hospitals within our neighbourhood. The cases were presented, and the questionnaire was administered in a confidential format. The orthopaedic surgeons were matched for age and practice, resulting in 74 cases being included in the analysis. Comparing the 2015 and 2020 results, we observed a notable increase in physicians who would perform “bone mineral density measurements of the lumbar spine and hip.” Furthermore, there was a significant rise in the percentage of respondents willing to test for bone metabolic markers, such as serum type I collagen cross-linked N-telopeptide (NTX), procollagen I N-terminal propeptide (P1NP), and tartrate-resistant acid phosphatase 5b (TRACP-5b). Regarding therapeutic agents, bisphosphonates decreased in usage, whereas parathyroid hormone and romosozumab witnessed an increase. In conclusion, the percentage of physicians requesting bone mineral density measurements of the lumbar spine and hip increased over the five-year period. In addition, more physicians chose to utilise bone metabolic markers due to their ease of measurement through blood tests and reduced diurnal variation. Finally, there was a marked trend towards the administration of drugs capable of rapidly and effectively increasing bone mineral density at an early stage of treatment. |
| format | Article |
| id | doaj-art-967386abf3f4429fb39b9ed89998c7e2 |
| institution | Kabale University |
| issn | 2042-0064 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Osteoporosis |
| spelling | doaj-art-967386abf3f4429fb39b9ed89998c7e22025-02-03T05:54:35ZengWileyJournal of Osteoporosis2042-00642024-01-01202410.1155/2024/9629891Changes in Testing and Treatment Methods in Osteoporosis CareTakashi Nagai0Koji Ishikawa1Koki Tsuchiya2Soji Tani3Yusuke Dodo4Yusuke Oshita5Keizo Sakamoto6Nobuyuki Kawate7Yoshifumi Kudo8Department of Rehabilitation MedicineDepartment of Orthopaedic SurgeryDepartment of Orthopaedic SurgeryDepartment of Orthopaedic SurgeryDepartment of Orthopaedic SurgeryDepartment of OrthopaedicDepartment of Orthopaedic SurgeryDepartment of Rehabilitation MedicineDepartment of Orthopaedic SurgeryOsteoporosis treatment plays a crucial role in preventing fractures, particularly in bedridden patients. We conducted a questionnaire survey presenting hypothetical clinical cases in 2015 and 2020 to investigate trends over a 5-year period. The target population included physicians working in clinics and hospitals within our neighbourhood. The cases were presented, and the questionnaire was administered in a confidential format. The orthopaedic surgeons were matched for age and practice, resulting in 74 cases being included in the analysis. Comparing the 2015 and 2020 results, we observed a notable increase in physicians who would perform “bone mineral density measurements of the lumbar spine and hip.” Furthermore, there was a significant rise in the percentage of respondents willing to test for bone metabolic markers, such as serum type I collagen cross-linked N-telopeptide (NTX), procollagen I N-terminal propeptide (P1NP), and tartrate-resistant acid phosphatase 5b (TRACP-5b). Regarding therapeutic agents, bisphosphonates decreased in usage, whereas parathyroid hormone and romosozumab witnessed an increase. In conclusion, the percentage of physicians requesting bone mineral density measurements of the lumbar spine and hip increased over the five-year period. In addition, more physicians chose to utilise bone metabolic markers due to their ease of measurement through blood tests and reduced diurnal variation. Finally, there was a marked trend towards the administration of drugs capable of rapidly and effectively increasing bone mineral density at an early stage of treatment.http://dx.doi.org/10.1155/2024/9629891 |
| spellingShingle | Takashi Nagai Koji Ishikawa Koki Tsuchiya Soji Tani Yusuke Dodo Yusuke Oshita Keizo Sakamoto Nobuyuki Kawate Yoshifumi Kudo Changes in Testing and Treatment Methods in Osteoporosis Care Journal of Osteoporosis |
| title | Changes in Testing and Treatment Methods in Osteoporosis Care |
| title_full | Changes in Testing and Treatment Methods in Osteoporosis Care |
| title_fullStr | Changes in Testing and Treatment Methods in Osteoporosis Care |
| title_full_unstemmed | Changes in Testing and Treatment Methods in Osteoporosis Care |
| title_short | Changes in Testing and Treatment Methods in Osteoporosis Care |
| title_sort | changes in testing and treatment methods in osteoporosis care |
| url | http://dx.doi.org/10.1155/2024/9629891 |
| work_keys_str_mv | AT takashinagai changesintestingandtreatmentmethodsinosteoporosiscare AT kojiishikawa changesintestingandtreatmentmethodsinosteoporosiscare AT kokitsuchiya changesintestingandtreatmentmethodsinosteoporosiscare AT sojitani changesintestingandtreatmentmethodsinosteoporosiscare AT yusukedodo changesintestingandtreatmentmethodsinosteoporosiscare AT yusukeoshita changesintestingandtreatmentmethodsinosteoporosiscare AT keizosakamoto changesintestingandtreatmentmethodsinosteoporosiscare AT nobuyukikawate changesintestingandtreatmentmethodsinosteoporosiscare AT yoshifumikudo changesintestingandtreatmentmethodsinosteoporosiscare |